Opendata, web and dolomites

SUPAIR Spectroscopy

SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPAIR Spectroscopy project word cloud

Explore the words cloud of the SUPAIR Spectroscopy project. It provides you a very rough idea of what is the project "SUPAIR Spectroscopy" about.

atr    distributors    poised    roadmap    business    biopharmaceutical    quality    flexible    total    pending    promoted    energy    biologic    spectrometer    exist    patent    first    analytical    mid    market    reactors    company    sme    merck    sensors    render    solution    price    industry    techniques    single    silicon    sterilization    innovation    2025    solutions    usually    awarded    billion    expensive    direct    savings    requiring    ftir    sales    costing    revenue    merits    crystal    reused    medical    read    valley    offers    scholarship    efficiency    impressive    companies    flow    performed    cultivating    cells    eliminates    optimal    time    carry    technologies    optical    consecutive    compact    bioreactors    commercial    feasibility    team    competing    b2b    transform    drugs    monitoring    sub    complete    mammalian    irubis    online    cell    size    model    pat    reflectance    consumption    customers    accelerator    streams    biopharma    water    150    monitored    spectroscopy    fourier    automated    affordable    infrared    200    attenuated    award    mir    half    500    probes    300   

Project "SUPAIR Spectroscopy" data sheet

The following table provides information about the project.

Coordinator
IRUBIS GMBH 

Organization address
address: SCHILLERSTRASSE 40 B
city: MUNCHEN
postcode: 80336
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://irubis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IRUBIS GMBH DE (MUNCHEN) coordinator 50˙000.00

Map

 Project objective

The biopharmaceutical industry is poised to reach an impressive market size of more than €300 billion by 2025. The production of biologic drugs is usually performed by cultivating mammalian cells within bioreactors. Those reactors are increasingly being monitored online by means of Process Analytical Technologies (PAT). However state-of-the-art techniques render both sub-optimal product quality and product efficiency. A complete mid-infrared (MIR) spectroscopy system using online Attenuated Total Reflectance (ATR) probes is highly expensive costing around €200,000, €20,000 only for the probes that are not robust enough, requiring consecutive sterilization to be reused (raising water and energy consumption). IRUBIS GmbH team goal is to make online monitoring of (single-use) bioreactors affordable. IRUBIS innovation comprises a single-use patent-pending silicon ATR crystal integrated in a single-use ATR Flow Cell which is read out by a compact Fourier Transform Infrared (FTIR) Spectrometer. IRUBIS Analytical Technology offers a system that will allow for the first time real-time process control (online) in single-use bioreactors. This means a flexible, highly automated system solution that costs half the price of the competing solutions. Furthermore, it eliminates sterilization requirements allowing for important energy savings. IRUBIS has been awarded an accelerator program promoted by Merck; Company recent merits also include the Medical valley award (€500,000) and the Exist scholarship (€150,000). Our business model will be based in two revenue streams: B2B direct sales of developed IRUBIS optical sensors to biopharma companies and sales through partnerships with distributors. The feasibility study we will carry out under this SME Phase 1 project, will define the technical, market and commercial roadmap allowing to offer customers a higher value product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPAIR SPECTROSCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPAIR SPECTROSCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More